|
2 Companies |
|
2 Products |
|
2 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
18 News |
|
- | NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Cell Therapy in Limb Girdle Muscular Dystrophy (clinicaltrials.gov) - Oct 25, 2018
P1, N=0, Withdrawn, Sponsor: Neurogen Brain and Spine Institute
N=65 --> 0 | Completed --> Withdrawn
- | NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Stem Cell Therapy in Limb Girdle Muscular Dystrophy (clinicaltrials.gov) - Oct 25, 2018
P1, N=0, Withdrawn, Sponsor: Neurogen Brain and Spine Institute
N=65 --> 0 | Completed --> Withdrawn N=65 --> 0 | Completed --> Withdrawn
- | lisinopril / Generic mfg.
Trial completion, Enrollment change: Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (clinicaltrials.gov) - Jun 15, 2018
P2/3, N=63, Completed, Sponsor: Cooperative International Neuromuscular Research Group
N=65 --> 0 | Completed --> Withdrawn Enrolling by invitation --> Completed | N=120 --> 63
- | Trial completion, Enrollment change: Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy (clinicaltrials.gov) - Jan 25, 2018
P=N/A, N=277, Completed, Sponsor: Nationwide Children's Hospital
Enrolling by invitation --> Completed | N=120 --> 63 Active, not recruiting --> Completed | N=500 --> 277
- Trial completion, Enrollment change, Trial primary completion date: Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I (clinicaltrials.gov) - Nov 14, 2016
P=N/A, N=38, Completed, Sponsor: Rigshospitalet, Denmark
Active, not recruiting --> Completed | N=500 --> 277 Recruiting --> Completed | N=50 --> 38 | Trial primary completion date: Jun 2015 --> Jan 2015
- Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Cell Therapy in Limb Girdle Muscular Dystrophy (clinicaltrials.gov) - Sep 26, 2016
P1, N=65, Completed, Sponsor: Neurogen Brain and Spine Institute
Recruiting --> Completed | N=50 --> 38 | Trial primary completion date: Jun 2015 --> Jan 2015 Recruiting --> Completed | N=200 --> 65 | Initiation date: Dec 2013 --> Dec 2010 | Trial primary completion date: Dec 2015 --> Jan 2015
- | lisinopril / Generic mfg.
Enrollment open, Trial primary completion date: Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (clinicaltrials.gov) - Feb 3, 2016
P2/3, N=120, Enrolling by invitation, Sponsor: Cooperative International Neuromuscular Research Group
Recruiting --> Completed | N=200 --> 65 | Initiation date: Dec 2013 --> Dec 2010 | Trial primary completion date: Dec 2015 --> Jan 2015 Active, not recruiting --> Enrolling by invitation | Trial primary completion date: Dec 2016 --> Dec 2017
- | lisinopril / Generic mfg.
Enrollment closed: Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (clinicaltrials.gov) - Oct 15, 2014
P2/3, N=120, Active, not recruiting, Sponsor: Cooperative International Neuromuscular Research Group
Active, not recruiting --> Enrolling by invitation | Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Active, not recruiting
- New P1 trial: Cell Therapy in Limb Girdle Muscular Dystrophy (clinicaltrials.gov) - Sep 22, 2014
P1, N=200, Recruiting, Sponsor: Neurogen Brain and Spine Institute
- Clinical: Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I (clinicaltrials.gov) - Jun 18, 2014
P=N/A, N=50, Recruiting, Sponsor: Rigshospitalet, Denmark
- Trial completion: Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy (clinicaltrials.gov) - Jun 2, 2014
P1, N=16, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment change: Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy (clinicaltrials.gov) - Jun 2, 2014
P1, N=20, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Completed N=36 --> 20
- Trial completion: Evaluation of Limb-Girdle Muscular Dystrophy (clinicaltrials.gov) - Mar 5, 2014
P=N/A, N=60, Completed, Sponsor: Cooperative International Neuromuscular Research Group
N=36 --> 20 Active, not recruiting --> Completed
- |||| NN1213 / Novo Nordisk
Trial completion: Study Evaluating MYO-029 in Adult Muscular Dystrophy (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=108, Completed, Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Active, not recruiting --> Completed No longer recruiting --> Completed
- New P1 trial: Stem Cell Therapy in Limb Girdle Muscular Dystrophy (clinicaltrials.gov) - Jan 29, 2014
P1, N=65, Completed, Sponsor: Neurogen Brain and Spine Institute
- Trial completion: Cardiac Outcome Measures in Children With Muscular Dystrophy (clinicaltrials.gov) - Jul 30, 2012
P=N/A, N=48, Completed, Sponsor: Cooperative International Neuromuscular Research Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) (clinicaltrials.gov) - Mar 21, 2012
P1, N=6, Completed, Sponsor: Nationwide Children's Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Cardiac Magnetic Resonance in Children With Muscular Dystrophy (clinicaltrials.gov) - Oct 25, 2011
P=N/A, N=20, Completed, Sponsor: Cooperative International Neuromuscular Research Group
Recruiting --> Completed Active, not recruiting --> Completed